Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

por Bringhen, Sara, Voorhees, Peter M., Plesner, Torben, Mellqvist, Ulf‐Henrik, Reeves, Brandi, Sonneveld, Pieter, Byrne, Catriona, Nordström, Eva, Harmenberg, Johan, Obermüller, Jakob, Richardson, Paul G.
Publicado 2021

P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS

por Miguel, Enrique Maria Ocio San, Efebera, Yvonne A., Hájek, Roman, Straub, Jan, Maisnar, Vladimir, Eveillard, Jean-Richard, Karlin, Lionel, Mateos, Maria-Victoria, Oriol, Albert, Ribrag, Vincent, Richardson, Paul, Norin, Stefan, Obermüller, Jakob, Bakker, Nicolaas A., Pour, Ludek
Publicado 2023